| Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma EE Sweeney, J Cano‐Mejia, R Fernandes Small 14 (20), 1800678, 2018 | 177 | 2018 |
| Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma J Cano-Mejia, RA Burga, EE Sweeney, JP Fisher, CM Bollard, ... Nanomedicine: Nanotechnology, Biology and Medicine, 2017 | 126 | 2017 |
| Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastoma J Cano-Mejia, M Bookstaver, E Sweeney, C Jewell, R Fernandes Biomaterials Science, 2019 | 38 | 2019 |
| CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma J Cano-Mejia, A Shukla, DK Ledezma, E Palmer, A Villagra, R Fernandes Translational Oncology 13 (10), 100823, 2020 | 32 | 2020 |
| Indocyanine green-nexturastat A-PLGA nanoparticles combine photothermal and epigenetic therapy for melanoma DK Ledezma, PB Balakrishnan, J Cano-Mejia, EE Sweeney, M Hadley, ... Nanomaterials 10 (1), 161, 2020 | 26 | 2020 |
| CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma PB Balakrishnan, DK Ledezma, J Cano-Mejia, J Andricovich, E Palmer, ... Nano research, 1-15, 2022 | 16 | 2022 |
| An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model A Shukla, J Cano-Mejia, J Andricovich, RA Burga, EE Sweeney, ... Advanced nanobiomed research 1 (8), 2100021, 2021 | 16 | 2021 |
| Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applications JM Vojtech, J Cano-Mejia, MF Dumont, RW Sze, R Fernandes JoVE (Journal of Visualized Experiments), e52621, 2015 | 15 | 2015 |
| Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof R Fernandes, RW Sze, CRY Cruz, AD Sandler, CM Bollard, EE Sweeney, ... US Patent 11,931,465, 2024 | 2 | 2024 |
| DAMPs‐coated Prussian blue nanoparticles as photothermal‐nanoimmunotherapy agents for cancer AJ Ruiz‐Justiz, J Cano‐Mejia, R Fernandes The FASEB Journal 33 (S1), 510.2-510.2, 2019 | 1 | 2019 |
| Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers J Cano-Mejia University of Maryland, 2015 | 1 | 2015 |
| Prussian blue nanoparticles functionalized with immune signals and applications thereof R Fernandes, E Sweeney, J Cano-Mejia US Patent 11,672,861, 2023 | | 2023 |
| PRUSSIAN BLUE NANOIMMUNOTHERAPIES FOR NEUROBLASTOMA J Cano-Mejia | | 2019 |
| Lymphocyte-nanoparticle biohybrids as a combined nanoimmunotherapy for cancer R Burga, J Cano-Mejia, RY Cruz, CM Bollard, R Fernandes | | 2017 |
| A Review of the Pathogenesis of Necrotizing Fasciitis by Group A Streptococci MF Campa, J Cano-Mejia, R Madenjian The Spectra, 26-33, 2012 | | 2012 |
Rohan FernandesAssociate Professor, George Washington UniversityVerified email at gwu.edu
